manufacturing defects – Page 14

Container closure mismatch during inspection – packaging vs process investigation

Packaging and Process Investigation of Container Closure Mismatch During Inspection Container closure mismatch during inspection can lead to significant production delays, product recalls, and compliance issues with regulatory agencies. This…

Container closure mismatch after transport simulation – packaging vs process investigation

Addressing Container Closure Mismatches After Transport Simulation: A Comprehensive Investigation In the highly regulated world of pharmaceutical manufacturing, maintaining the integrity of packaging systems is crucial to ensuring product quality…

Patch curling during stability pull – inspection finding risk

Investigating Patch Curling during Stability Pull: A Guide for Quality Professionals During the stability testing of transdermal patches, one alarming observation can indicate potential quality control issues: patch curling. This…

Coating weight variability during patch manufacturing – inspection finding risk

Understanding Coating Weight Variation in Patch Manufacturing: A Guide to Investigation and Resolution In the realm of transdermal patch manufacturing, coating weight variability is an inspection finding that can raise…

Drug crystallization during patch manufacturing – CAPA documentation failure

Understanding Drug Crystallization in Patch Manufacturing: A Guide for CAPA Documentation Drug crystallization during patch manufacturing can pose significant challenges to quality assurance in the pharmaceutical sector. This issue not…

Patch curling after adhesive change – process vs material root cause

Investigating Patch Curling After An Adhesive Change in Pharmaceutical Manufacturing In pharmaceutical manufacturing, unexpected defects such as patch curling after an adhesive change can present significant challenges. Such issues impact…

Patch curling during stability pull – CAPA documentation failure

Understanding and Investigating Patch Curling During Stability Pulls In the realm of pharmaceutical manufacturing, deviations and out-of-specification (OOS) results present significant challenges. One notable concern is the patch curling during…

Coating weight variability during storage – process vs material root cause

Understanding Coating Weight Variability During Storage: Identifying Process and Material Root Causes Coating weight variability during storage can lead to significant challenges in pharmaceutical manufacturing, especially for products like transdermal…

Residual solvent OOS after adhesive change – inspection finding risk

Investigating Residual Solvent Out-of-Specification Results After Adhesive Change: A Comprehensive Approach In the pharmaceutical manufacturing landscape, out-of-specification (OOS) results can pose significant challenges, particularly when they arise after a change…

Adhesion failure during patch manufacturing – process vs material root cause

Understanding Adhesion Failures in Patch Manufacturing: An Investigation Approach Adhesion failures during transdermal patch manufacturing can pose significant challenges for pharmaceutical manufacturers, leading to potential product recalls, compliance issues, and…

Drug crystallization during storage – process vs material root cause

Investigation of Drug Crystallization During Storage: Identifying Process and Material Root Causes Drug crystallization during storage can pose significant challenges in pharmaceutical manufacturing, particularly for transdermal patches. Such occurrences raise…

Backing delamination during stability pull – process vs material root cause

Examining Backing Delamination During Stability Pull: A Root Cause Analysis Approach The phenomenon of backing delamination during stability pulls is a significant concern in the pharmaceutical industry, particularly for transdermal…